Tuesday, October 02, 2012

I Learn of Two More RU-486 Deaths

Some time in 2008, 29-year-old "Carmen" Roe began a regimen for an RU-486 abortion. She was a Hispanic woman with diabetes. She was given 200 mg of mifepristone orally and 800 units of misoprostol vaginally at 5 weeks of gestation. Despite the documented infection risk, she was not provided with antibiotics. Four days after starting the abortion, Carmen experienced severe cramping, vomiting, and diarrhea. The next day she was admitted to a hospital; her heart was racing and she had abnormal blood test results indicating infection. Exploratory surgery was performed, showing a massive amount of greenish-brown fluid in her abdomen. Parts of her uterus and surrounding tissue were dead and rotting, so a complete hysterectomy was performed. However, in spite of the surgery her blood pressure dropped. She died on the sixth day after the start of the abortion, of massive infection and respiratory distress syndrome.

"Belle" Roe, a 21-year-old white woman, had been in good health when she went to an abortion facility in 2009. She was 7 weeks pregnant and had chosen a chemical abortion. She was given 200 mg of oral mifepristone and 800 μg of vaginal misoprostol. In spite of the known risk of fatal infection, she was not given antibiotics. Six days after beginning the abortion, Belle suffered extreme cramping, diarrhea, and vomiting. The next day she was brought to the hospital with a rapid pulse, low blood pressure, fluid on the lungs, and signs of massive infection. A dilation and evacuation procedure was performed to remove infected tissue from her uterus, and excessive fluids were repeatedly drained. Nevertheless, 12 days after the abortion was initiated, Belle died of severe infection, kidney failure, and a disseminated intravascular coagulopahty (a serious clotting disorder).

Other chemical abortion deaths in the U.S. include Holly Patterson, Wanda Roe Vivian Tran, Cherish Roe, Tara Roe, Chanelle Bryant, Oriane Shevin, and Brenda Vise .

HT: Life News

No comments: